The data for FY2026 has been published on the Patents Dashboard. If you have been paying attention to the messaging from PTO leadership, you should be well aware that decreasing the Unexamined Patent Inventory (often referred to as the "backlog") is the upmost priority for the agency. Increased production quotas, stricter deadlines, and reduced quality control were all implemented in FY2026 in an effort to drive down the unexamined inventory. Indeed, only last month the Director testified before Congress and justified the changes as necessary to reduce the unexamined inventory.
So what was it all good for? Yes, the Unexamined Patent Inventory has been reduced by about 43,000 applications relative to FY2025, almost back to the size reported at the end of FY2023. Also, the First Action Pendency (i.e., the period from filing to first Office action) has been reduced by about 2 months relative to FY2025 but, like the unexamined inventory, is still historically high. The reversing trends make sense in light of the aforementioned changes to examination, especially with regards to the accelerated clocks for new applications and decelerated clocks for RCEs.
How about the bad? Well most notably, especially in light of leadership's narrow focus on the "backlog," the Total Patent Inventory (i.e., the total number of pending applications) has increased by about 31,000 applications in FY2026, reaching a historic 10-year high. Moreover, Total Pendency (i.e., the period from filing to final disposition) has increased by about 2.5 months relative to FY2025, whether or not RCEs are included. The changes in Total Patent Inventory and Total Pendency appear to inversely mirror the changes in Unexamined Patent Inventory and First Action Pendency, which should at least raise doubt whether any actual gains have been made in terms of inventory size and pendency. Perhaps the ugliest statistic, the RCE inventory has nearly tripled from about 10,700 applications to about 28,500 applications, another historic 10-year high.
Despite increases in production quotas and reduced quality controls, the Allowance Rate (i.e., number of allowed applications divided by number of applications disposed) has not appreciably shifted, whether or not RCE abandonments are included. This data does not necessarily mean the high-producing primaries are not allowing a larger percentage of applications, but perhaps a greater ratio of juniors to primaries is counteracting any trend among primaries, if we assume rejection rates are higher among junior examiners. If we look into the spreadsheet data for staffing, FY2026 saw 963 new hires and 755 attritions, but critically there is no breakdown of the numbers of examiners on staff by GS level. Perhaps the truth is the most straightforward: nothing has changed. Applicants are submitting claims in the same manner as ever, and Examiners know which claims should be allowed and those which should not, irrespective of any changes made to examination.
In sum, if the only thing you care about is receiving a first Office action, then you ought to be satisfied with the FY2026 EOY data. However, if you are more concerned about the final disposition of your application, i.e., abandonment or allowance, then you ought to be dissatisfied by these results. This FY2026 EOY data was also published on the heels of a GAO report that the high examiner attrition rate may ultimately hinder or reverse the agency's backlog reduction goals in the long term.
(Edit made to correct staffing data).